Demant A/S (CPH:DEMANT)

Market Cap	39.94B -36.7%
Revenue (ttm)	22.97B +2.5%
Net Income	1.55B -35.3%
EPS	7.31 -33.5%
Shares Out	210.90M
PE Ratio	16.91
Forward PE	15.10
Dividend	n/a
Ex-Dividend Date	n/a

Volume	258,958
Average Volume	580,202
Open	192.30
Previous Close	189.40
Day's Range	185.50 - 194.10
52-Week Range	175.00 - 293.00
Beta	0.88
RSI	38.68
Earnings Date	Feb 3, 2026

About Demant

Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1904
• Employees: 26,704
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: DEMANT

Financial Performance

In 2025, Demant's revenue was 22.97 billion, an increase of 2.46% compared to the previous year's 22.42 billion. Earnings were 1.55 billion, a decrease of -35.27%.